首页|氟西汀联合阿立哌唑治疗抑郁症的临床效果及对患者睡眠质量的影响

氟西汀联合阿立哌唑治疗抑郁症的临床效果及对患者睡眠质量的影响

扫码查看
目的 研究氟西汀联合阿立哌唑治疗抑郁症的临床效果及对患者睡眠质量的影响。方法 选取2021年4月-2023年4月天津建华医院收治的98例抑郁症患者,采用随机数字表法分为对照组与观察组,各49例。对照组接受氟西汀治疗,观察组在其基础上联合阿立哌唑治疗。比较两组临床疗效、抑郁症状[汉密尔顿抑郁量表(HAMD)、Beck抑郁问卷(BDI)]、负性自动思维问卷(ATQ)、匹兹堡睡眠质量指数(PSQI)及Connor-Davidson心理弹性量表(CD-RISC)评分。结果 观察组总有效率高于对照组(P<0。05);2组HAMD、BDI评分低于治疗前,且观察组HAMD、BDI评分低于对照组(P<0。05);2组ATQ评分低于治疗前,且观察组ATQ评分低于对照组(P<0。05);2组PSQI评分低于治疗前,CD-RISC评分高于治疗前,且观察组PSQI评分低于对照组,CD-RISC评分高于对照组(P<0。05)。结论 氟西汀联合阿立哌唑在抑郁症治疗中可发挥确切作用,其临床疗效突出,可减轻患者抑郁症状,消除负性思维,改善其睡眠质量与心理弹性。
Clinical Effect of Fluoxetine Combined with Aripiprazole in the Treatment of Depression and its Effect on Sleep Quality
Objective To study the clinical effect of fluoxetine combined with aripiprazole in the treatment of depression and its effect on sleep quality.Methods A total of 98 patients with depression admitted to Tianjin Jianhua Hospital from April 2021 to April 2023 were selected and divided into control group and observation group by random number table method,with 49 patients in each group.The control group was treated with fluoxetine,and the observation group was treated with aripiprazole on the basis of the control group.The clinical efficacy,depressive symptoms[Hamilton Depression Scale(HAMD),Beck Depression Inventory(BDI)],Automatic Thought Questionnaire(ATQ),Pittsburgh Sleep Quality Index(PSQI)and Connor-Davidson Resilience Scale(CD-RISC)scores were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group(P<0.05).The scores of HAMD and BDI in the two groups after treatment were lower than those before treatment,and the scores of HAMD and BDI in the observation group were lower than those in the control group(P<0.05).After treatment,the ATQ scores(frequency and confidence)of the two groups were lower than those before treatment,and the ATQ scores(frequency and confidence)of the observation group were lower than those of the control group(P<0.05).The PSQI score of the two groups after treatment was lower than that before treatment,and the CD-RISC score was higher than that before treatment,while the PSQI score of the observation group was lower than that of the control group,and the CD-RISC score was higher than that of the control group(P<0.05).Conclusion Fluoxetine combined with aripiprazole can play an exact role in the treatment of depression,and its clinical efficacy is outstanding.Meanwhile,it can reduce the depressive symptoms of patients,eliminate negative thinking,and improve their sleep quality and psychological elasticity.

DepressionFluoxetineAripiprazoleSleep qualityPsychological resilienceNegative thinking

李书元

展开 >

天津建华医院精神康复二科,天津 300393

抑郁症 氟西汀 阿立哌唑 睡眠质量 心理弹性 负性思维

2024

医学信息
国家卫生部信息化管理领导小组 中国电子学会中国医药信息学分会 陕西文博生物信息工程研究所

医学信息

影响因子:0.161
ISSN:1006-1959
年,卷(期):2024.37(2)
  • 22